Corruption, Innovation, and Corporate Greed

This chapter investigates the interplay between corporate interests and public health, highlighting corruption within regulatory bodies like the FDA and the consequences of profit-driven policies. It discusses alarming systemic failures that lead to medical and environmental crises, while also reflecting on controversial technologies and the threats faced by innovative thinkers. The conversation challenges listeners to remain skeptical and advocate for ethical practices in both health and energy sectors.